Back to search

Article

A Decision Support System for Preclinical Assessment of Nanomaterials in Medical Products: The REFINE DSS

2022-01-17

Abstract excerpt

<title>Abstract</title> <p>The application of nanomaterials in medicine has led to novel pharmaceuticals and medical devices that have demonstrated a strong potential for increasing the efficacy/performance and safety of therapeutic and diagnostic procedures to address a wide range of diseases. However, the successful translation of these technologies from their inception (proof-of-concept) to clinical practice h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6171aecc-1c92-5cfe-972b-c999acedb1ea
DOI
10.21203/rs.3.rs-1246960/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Decision Support System for Preclinical Assessment of Nanomaterials in Medical Products: The REFINE DSSDOI 10.21203/rs.3.rs-1246960/v1
Artificial Intelligence-Augmented Analytical Method Development and Validation in Pharmaceutical Manufacturing: Current Applications, Regulatory Landscape, and Future DirectionsSemantic proximity
Toxishield: Computational Analyser for Food Additives and their Health ImplicationsSemantic proximity
An ex vivo human model for safety assessment of immunotoxicity of engineered nanomaterialsSemantic proximity
EU’s Medical Device Expert Panels: Analysis of Membership and Published Clinical Evaluation Consultation Procedure (CECP) ResultsSemantic proximity
U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Semantic proximity
How the HTAR will contribute to a value-based decision making for medicinal products across the EUSemantic proximity
Advancing Potency Assay Development for Advanced Therapy Medicinal Products: A Comprehensive Approach and Regulatory InsightsSemantic proximity
Towards better preclinical research: Key takeaways from confirmatory multi-laboratory trials and stakeholder discussionsSemantic proximity
Towards better preclinical research: Key takeaways from confirmatory multi-laboratory trials and stakeholder discussionsSemantic proximity
Interpretable AI Decision-Support for Pre-IND Drug Development in a Historically Animal-Approved Cohort: A Large Concept Model FrameworkSemantic proximity
Statistical Methodology for Qualification of a Non-Clinical Risk Assessment Peptide:T Cell Proliferation Assay to Support Decision MakingSemantic proximity
NANO.PTML Model for read-across prediction of nanosystems in neurosciences. Computational model and experimental case of studySemantic proximity
Select a neighboring publication to make it the new centre.